Literature DB >> 17406614

The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation.

Adriana Albini1, Roberto Benelli.   

Abstract

Invasive and metastatic cells, as well as endothelial cells, must cross basement membranes (BMs) in order to disseminate or to form new blood vessels. The chemoinvasion assay using the reconstituted BM Matrigel in Boyden blind-well chambers is a very rapid, easy, inexpensive and flexible test that can be used to quantify the invasive potential of most cell types; it can be applied to detect the migratory activity associated with matrix degradation and can also be adapted to study the selective degrading activity on different matrix substrates. Transwell inserts can also be used. Once the optimal experimental conditions are empirically determined for specific cellular models, the chemoinvasion assay can be used for the screening of inhibitors of invasiveness and angiogenesis, or to select for invasive cellular populations. This protocol can be completed in 9 h.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406614     DOI: 10.1038/nprot.2006.466

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  80 in total

1.  Immunomodulatory glc/man-directed Dolichos lablab lectin (DLL) evokes anti-tumour response in vivo by counteracting angiogenic gene expressions.

Authors:  V Vigneshwaran; P Thirusangu; B R Vijay Avin; V Krishna; S N Pramod; B T Prabhakar
Journal:  Clin Exp Immunol       Date:  2017-04-05       Impact factor: 4.330

2.  Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer.

Authors:  Anika Agarwal; Lidija Covic; Leila M Sevigny; Nicole C Kaneider; Katherine Lazarides; Gissou Azabdaftari; Sheida Sharifi; Athan Kuliopulos
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

3.  In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract.

Authors:  Irina Arnaoutova; Hynda K Kleinman
Journal:  Nat Protoc       Date:  2010-03-11       Impact factor: 13.491

4.  Quantification of cancer cell extravasation in vivo.

Authors:  Yohan Kim; Karla C Williams; Carson T Gavin; Emily Jardine; Ann F Chambers; Hon S Leong
Journal:  Nat Protoc       Date:  2016-04-21       Impact factor: 13.491

5.  Transparent reporting of experimental parameters in assays measuring phenotypic steps in metastasis.

Authors:  Robin Boiy; Jonas Steenbrugge; Jan Van Deun; An Hendrix; Evelyne Meyer; Olivier De Wever
Journal:  Clin Exp Metastasis       Date:  2018-10-28       Impact factor: 5.150

6.  An isolated tumor perfusion model in mice.

Authors:  Annique M M J Duyverman; Mitsutomo Kohno; Sylvie Roberge; Dai Fukumura; Dan G Duda; Rakesh K Jain
Journal:  Nat Protoc       Date:  2012-03-22       Impact factor: 13.491

7.  A transient parabiosis skin transplantation model in mice.

Authors:  Annique M M J Duyverman; Mitsutomo Kohno; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Nat Protoc       Date:  2012-03-22       Impact factor: 13.491

8.  Multi-Domain Photopatterned 3D Tumor Constructs in a Micro-Physiological System for Analysis, Quantification, and Isolation of Infiltrating Cells.

Authors:  Shiny A P Rajan; Aleksander Skardal; Adam R Hall
Journal:  Adv Biosyst       Date:  2020-02-25

9.  Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage.

Authors:  Matteo Centola; Franca Abbruzzese; Celeste Scotti; Andrea Barbero; Gianluca Vadalà; Vincenzo Denaro; Ivan Martin; Marcella Trombetta; Alberto Rainer; Anna Marsano
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

10.  Requirement of arsenic biomethylation for oxidative DNA damage.

Authors:  Chikara Kojima; Dario C Ramirez; Erik J Tokar; Seiichiro Himeno; Zuzana Drobná; Miroslav Stýblo; Ronald P Mason; Michael P Waalkes
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.